Heart Valve Technology

This channel includes news and new device innovations about heart valve technologies, including the aortic valve, mitral valve, pulmonic valve, and tricuspid valve. This includes information on transcatheter valve technologies like transcatheter aortic valve replacement (TAVR, or implantation TAVI), transcatheter mitral valve repair or replacement (TMVR), transcatheter and surgical valve repairs, and surgical replacement valves. Newer devices are now being used for transcatheter tricuspid valve repair replacement (TTVR). 

The VitalPatch RTM biosensor is being used in the TELESTAR-TAVR clinical study (Deployment of Telemedicine for Symptom Tracking And Decrease Readmission Rate in TAVR Patients). It will evaluate patients who undergo a transcatheter aortic valve replacement (TAVR) and monitor them following the procedure utilizing the latest technology from VitalConnect, VistaSolution LIVE. 

The VitalPatch RTM biosensor is being used in the TELESTAR-TAVR clinical study to evaluate patients who undergo a transcatheter aortic valve replacement (TAVR) and monitor them following the procedure utilizing the latest technology from VitalConnect, VistaSolution LIVE. 

News | Wearables | September 25, 2020
September 25, 2020 — Remote and in-hospital wearable biosensor technology company VitalConnect Inc. has started the...
TCT 2020 Late-breaking Study trial Presentations Announced. #TCTconnect #TCT2020 #TCT
Feature | TCT | October 29, 2020
October 29, 2020 — The late-breaking studies are one of the hallmarks of the annual Transcatheter Cardiovascular...
Videos | Structural Heart | September 16, 2020
Juan F. Granada, M.D., CEO of the Cardiovascular Research Foundation (CRF) explains structural heart innovations and...
Medtronic announced U.S. Food and Drug Administration (FDA) approval of an early feasibility study (EFS) of the Intrepid Transcatheter Tricuspid Valve Replacement (TTVR) system. The study begins on the heels of a recent Breakthrough Device Designation issued by the FDA for the Intrepid TTVR System. The Intrepid TTVR system is an investigational device worldwide.
News | Heart Valve Technology | September 11, 2020
September 11, 2020 – Medtronic announced U.S. Food and Drug Administration (FDA) approval of an early feasibility study...
An example of a 80-year-old TAVR patient planning CT scan from Northwestern Medicine's Central DuPage Hospital. This was used in a heart team meeting with the TAVR staff, including a cardiac surgeon and interventional cardiologist, to determine if this patient was eligable for TAVR, the best access routes to deliver the valve, device valve size needed, and to look for any potential anatomical issues so they can be planned for. 

An example of a 80-year-old TAVR patient planning CT scan from Northwestern Medicine's Central DuPage Hospital. This was used in a heart team meeting with the TAVR staff, including a cardiac surgeon and interventional cardiologist, to determine if this patient was eligible for TAVR, the best access routes to deliver the valve, device valve size needed, and to look for any potential anatomical issues so they can be planned for.

News | Structural Heart | September 02, 2020
September 2, 2020 — Northwestern Medicine Bluhm Cardiovascular Institute physicians recently completed their 2,000th...
Researchers 3-D Print Lifelike Heart Valve Models with embedded sensor technology
News | Medical 3-D Printing | September 02, 2020
September 2, 2020 — Patient-specific organ models are being used by the University of Minnesota to better prepare for...
Navin Kapur, M.D., FAHA, FACC, FSCAI, executive director, The CardioVascular Center for Research and Innovation (CVCRI), explains the concpet of the Door-to-Unloading (DTU) Trial he is heading, one of several innovations at Tufts Medical Center in Boston. Kapur is also director, Acute Mechanical Circulatory Support Program; director, interventional research laboratories; director of Cardiac Biology Research Center, Molecular Cardiology Research Institute (MCRI), Tufts Medical Center. Photo by Dave Fornell

Navin Kapur, M.D., FAHA, FACC, FSCAI, executive director, The CardioVascular Center for Research and Innovation (CVCRI), explains the concpet of the Door-to-Unloading (DTU) Trial he is heading, one of several innovations at Tufts Medical Center in Boston. Kapur is also director, Acute Mechanical Circulatory Support Program; director, interventional research laboratories; director of Cardiac Biology Research Center, Molecular Cardiology Research Institute (MCRI), Tufts Medical Center. Photo by Dave Fornell

Feature | Tufts Medical Center | August 21, 2020 | Dave Fornell, Editor
The cardiology program at Tufts Medical Center in Boston is internationally recognized for being on the forefront of...
National Survey Of Heart Valve Patients Shows Importance Of Seeking Treatment Early
News | Heart Valve Technology | August 12, 2020
August 12, 2020 — A national survey conducted by the patient advocacy group Heart-Valve-Surgery.com with support by...
CardioMech's transcatheter chordae tendineae repair system uses a catheter to attach an anchor on the mitral valve leaflet and then attaches it via a cord to the apex of the heart.

CardioMech's transcatheter chordae tendineae repair system uses a catheter to attach an anchor on the mitral valve leaflet and then attaches it via a cord to the apex of the heart.

News | Heart Valve Technology | August 05, 2020
August 5, 2020 – Minneapolis-based CardioMech AS, a medical device company developing a transfemoral, transseptally...
Two of the top pieces of content in July included the FDA clearance for the new Watchman FLX left atrial appendage occluder (left), which includes a video interview with one of the trial investigators. COVID-19 content remained among the top content in July, and one story explained the odd pattern of cardiac cell death in COVID-19 patient autopsies. 

Two of the top pieces of content in July included the FDA clearance for the new Watchman FLX left atrial appendage occluder (left), which includes a video interview with one of the trial investigators. COVID-19 content remained among the top content in July, and one story explained the odd pattern of cardiac cell death in COVID-19 patient autopsies.

Feature | August 03, 2020 | Dave Fornell, Editor
August 3, 2020 — Here is the list of the most popular content on the Diagnostic and Interventional Cardiology (DAIC)...
A cardiac CT of a patient with pacemaker leads, which can be challenging to get good images due to metal artifact. This image was rendered from using Canon's AiCE AI-assisted interactive reconstruction with Global Illumination 3-D rendering from a scan on an Aquilion One Genesis SP system.

A cardiac CT of a patient with pacemaker leads, which can be challenging to get good images due to metal artifact. This image was rendered from using Canon's AiCE AI-assisted interactive reconstruction with Global Illumination 3-D rendering from a scan on an Aquilion One Genesis SP system.

Feature | CT Angiography (CTA) | July 27, 2020 | Dave Fornell, Editor
There has been tremendous growth in the field of cardiovascular computed tomography (CT) in the past two decades, with...
The Edwards Konect Resilia aortic valved conduit (AVC).
News | Heart Valve Technology | July 15, 2020
July 15, 2020 —  The U.S. Food and Drug Administration (FDA) granted clearance for the Edwards Lifesciences Corp....
A comparison of the Edwards Pascal (left) and the Abbott MitraClip used for transcatheter mitral and tricuspid valve leaflet repairs. The two companies settled patent litigation regarding the devices today.
News | Structural Heart | July 13, 2020
July 13, 2020 — Edwards Lifesciences Corp. and Abbott Vascular announced the two companies have reached an agreement to...
Three of the most popular cardiovascular technologies to make news in June 2020. Top is the Impella Expandable Cardiac Pump (ECP) that is about to enter U.S. feasibility trials.Bottom left, the Foldax heart valve uses a flexible man-made material for valve leaflets rather than animal pericardium tissue. The hope is this new type of surgical and transcatheter aortic valve replacements (TAVR) device will enhance longevity of the valve leaflets. Bottom right, the SMT Hydra TAVR valve is the first Indian-made s

Three of the most popular cardiovascular technologies to make the top news in June 2020. Top is the Impella Expandable Cardiac Pump (ECP) that is about to enter U.S. feasibility trials.Bottom left, the Foldax heart valve uses a flexible man-made material for valve leaflets rather than animal pericardium tissue. The hope is this new type of surgical and transcatheter aortic valve replacements (TAVR) device will enhance longevity of the valve leaflets. Bottom right, the SMT Hydra TAVR valve is the first Indian-made structural heart devices to gain European CE mark approval.

Feature | July 06, 2020
July 6, 2020 — Here is the list of the most popular content on the Diagnostic and Interventional Cardiology (DAIC)...
The Foldax Tria surgical valve reimagines the heart valve by incorporating a new, proprietary biopolymer, what the vendor calls LifePolymer, with an innovative valve design intended to eliminate calcification, withstand stresses and strains without failure, and restore patient quality of life without lifelong use of anticoagulants. Tria is also the first heart valve to be robotically manufactured, reducing variability, enabling high precision, repeatability and better quality control.
News | Heart Valve Technology | June 23, 2020
June 23, 2020 – Heart valve start-up Foldax is looking to reinventing several aspects of the prosthetic heart valve,...